ZA200900165B - 4-amino-3-arylamino-6-arylpyrazolo[3,4-D]pyrimidine derivatives, methods for their preparation and their use as antiviral agents - Google Patents

4-amino-3-arylamino-6-arylpyrazolo[3,4-D]pyrimidine derivatives, methods for their preparation and their use as antiviral agents

Info

Publication number
ZA200900165B
ZA200900165B ZA200900165A ZA200900165A ZA200900165B ZA 200900165 B ZA200900165 B ZA 200900165B ZA 200900165 A ZA200900165 A ZA 200900165A ZA 200900165 A ZA200900165 A ZA 200900165A ZA 200900165 B ZA200900165 B ZA 200900165B
Authority
ZA
South Africa
Prior art keywords
arylpyrazolo
arylamino
amino
preparation
antiviral agents
Prior art date
Application number
ZA200900165A
Other languages
English (en)
Inventor
Vadim Makarov
Peter Wutzler
Michaela Schmidtke
Hans-Martin Dahse
Original Assignee
Dritte Patentportfolio Beteili
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dritte Patentportfolio Beteili filed Critical Dritte Patentportfolio Beteili
Publication of ZA200900165B publication Critical patent/ZA200900165B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200900165A 2006-06-22 2009-01-08 4-amino-3-arylamino-6-arylpyrazolo[3,4-D]pyrimidine derivatives, methods for their preparation and their use as antiviral agents ZA200900165B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006029074A DE102006029074A1 (de) 2006-06-22 2006-06-22 4-Amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidin-Derivate, Verfahren zu ihrer Herstellung und deren Verwendung als antivirale Wirkstoffe

Publications (1)

Publication Number Publication Date
ZA200900165B true ZA200900165B (en) 2009-12-30

Family

ID=38606873

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200900165A ZA200900165B (en) 2006-06-22 2009-01-08 4-amino-3-arylamino-6-arylpyrazolo[3,4-D]pyrimidine derivatives, methods for their preparation and their use as antiviral agents

Country Status (18)

Country Link
US (1) US8962634B2 (es)
EP (1) EP2049540B1 (es)
JP (1) JP5171815B2 (es)
KR (1) KR101107839B1 (es)
CN (1) CN101553489B (es)
AT (1) ATE492548T1 (es)
AU (1) AU2007262524B2 (es)
BR (1) BRPI0713488B1 (es)
CA (1) CA2655754C (es)
DE (2) DE102006029074A1 (es)
ES (1) ES2359677T3 (es)
IL (1) IL195837A0 (es)
NO (1) NO20090332L (es)
NZ (1) NZ573849A (es)
RU (1) RU2456288C2 (es)
SG (1) SG173316A1 (es)
WO (1) WO2007147401A1 (es)
ZA (1) ZA200900165B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102507287B1 (ko) * 2011-09-02 2023-03-07 인사이트 홀딩스 코포레이션 Ｐｉ３ｋ 억제제로서 헤테로시클릴아민
LT2766367T (lt) * 2011-10-14 2022-08-25 Scandion Oncology A/S 4-amino-3-fenilamino-6-fenilpirazol[3,4-d]pirimidino derivatai virusinėms infekcijoms, ypač pikornaviruso infekcijai, gydyti
DE102011116373A1 (de) 2011-10-14 2013-04-18 Dritte Patentportfolio Beteiligungsgesellschaft Mbh & Co.Kg Methode zur Herstellung von 4-Amino-3-arylamino-6-arylpyrazolo[3, 4-d]pyrimidinen
DE102012004736A1 (de) 2011-10-20 2013-04-25 Dritte Patentportfolio Beteiligungsgesellschaft Mbh & Co.Kg 4-Amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidin-Derivate und deren Verwendung als antivirale Wirkstoffe
WO2016044656A1 (en) 2014-09-17 2016-03-24 Ansun Biopharma, Inc. Treatment of infection by human enterovirus d68
EP3064207B1 (en) 2015-03-04 2017-12-20 Scandion Oncology A/S 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives for use as BCRP inhibitors in therapeutic treatments

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2965643A (en) * 1960-12-20 Derivatives of pyrazolo
US3551428A (en) * 1956-02-10 1970-12-29 Ciba Geigy Corp New 1- (or 2-) substituted 4-mercapto-pyrazolo(3,4-d)pyrimidines
DE1088503B (de) * 1957-12-06 1960-09-08 Ciba Geigy Verfahren zur Herstellung von 3-Amino-pyrazolo-[3,4-d]-pyrimidinen
DE3712735A1 (de) * 1987-04-15 1988-11-10 Boehringer Mannheim Gmbh Neue pyrazolo(3,4-d)pyrimidine, verfahren zu ihrer herstellung und verwendung als arzneimittel
FI933303L (fi) 1991-01-23 1993-08-31 Gensia Inc Adenosinkinasinhibitorer
US5294612A (en) * 1992-03-30 1994-03-15 Sterling Winthrop Inc. 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
TW370529B (en) 1992-12-17 1999-09-21 Pfizer Pyrazolopyrimidines
US5646152A (en) 1994-06-15 1997-07-08 Pfizer Inc. Methods of administering CRF antagonists
CZ27399A3 (cs) * 1999-01-26 2000-08-16 Ústav Experimentální Botaniky Av Čr Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
AU2005219517A1 (en) * 2004-02-27 2005-09-15 F.Hoffmann-La Roche Ag Heteroaryl-fused pyrazolo derivatives
WO2006035061A1 (en) * 2004-09-30 2006-04-06 Tibotec Pharmaceuticals Ltd. Hcv inhibiting bi-cyclic pyrimidines

Also Published As

Publication number Publication date
KR20090071536A (ko) 2009-07-01
IL195837A0 (en) 2009-09-01
JP5171815B2 (ja) 2013-03-27
ES2359677T3 (es) 2011-05-25
KR101107839B1 (ko) 2012-02-09
US8962634B2 (en) 2015-02-24
CA2655754C (en) 2012-02-07
DE502007006042D1 (de) 2011-02-03
JP2009541230A (ja) 2009-11-26
DE102006029074A1 (de) 2007-12-27
RU2009101920A (ru) 2010-07-27
EP2049540A1 (de) 2009-04-22
BRPI0713488B1 (pt) 2022-04-12
SG173316A1 (en) 2011-08-29
AU2007262524B2 (en) 2011-12-01
RU2456288C2 (ru) 2012-07-20
ATE492548T1 (de) 2011-01-15
NO20090332L (no) 2009-03-12
CA2655754A1 (en) 2007-12-27
NZ573849A (en) 2011-11-25
WO2007147401A1 (de) 2007-12-27
CN101553489B (zh) 2013-07-17
US20100010018A1 (en) 2010-01-14
CN101553489A (zh) 2009-10-07
AU2007262524A1 (en) 2007-12-27
BRPI0713488A2 (pt) 2012-10-23
EP2049540B1 (de) 2010-12-22

Similar Documents

Publication Publication Date Title
PL2012759T3 (pl) Pochodne puryny jako agoniści receptora A2A
NO20063231L (no) Pyrido[2,3-D]pyrimidin-2,4-diaminer som PDE 2 inhibitorer
GEP20156282B (en) Compounds and compositions as protein kinase inhibitors
MX2010006107A (es) Derivados de espiroindolinona.
TNSN08478A1 (en) Pyrazolo [3,4-d] pyrimidine derivatives useful to treat respiratory disorders
GEP20135780B (en) Novel pyrazolo [3,4-d] pyrimidine derivatives as anti-cancer agents
WO2007146124A3 (en) Deuterated tadalafil derivatives
MX2012004089A (es) Inhibidores de hsp90.
WO2007121921A3 (en) Purine derivatives for use as adenosin a2a receptor agonists
SG151254A1 (en) Substituted morpholine and thiomorpholine derivatives
MX2010006748A (es) Pirazolo[1,5-a]pirimidinas utiles como inhibidores de jak2.
MXPA05007516A (es) Derivados de hexahidropirazino[1,2-a]pirimidina -4, 7-diona sustituidos, metodo para producirlos y su uso como medicamentos.
EA200970669A1 (ru) Производные 2-амино-5,7-дигидро-6н-пирроло[3,4-d]пиримидина в качестве ингибиторов hsp-90, предназначенные для лечения рака
MY150747A (en) Pyrido[2,3-d] pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer
IL191751A0 (en) Pyrrolo[2,3-c]pyridine derivatives
WO2006116733A3 (en) Protein kinase inhibitors
ZA200900165B (en) 4-amino-3-arylamino-6-arylpyrazolo[3,4-D]pyrimidine derivatives, methods for their preparation and their use as antiviral agents
ATE496918T1 (de) Als a2b-adenosinrezeptorantagonisten geeignete 5- phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazoä4, - büpyridin-2-onderivate
GEP20105095B (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
TNSN08369A1 (en) Benzimidazole derivatives
WO2008104473A3 (en) Pyrazolopyriidine derivatives and their use as kinase inhibitors
TW200633964A (en) Tetralin and indane derivatives and uses thereof
GEP20104875B (en) Pyrimidine derivatives for the treatment of abnormal cell growth
WO2009034547A3 (en) New 4-substituted derivatives of pyrazolo[3,4-d pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof
IL191928A0 (en) Triazoloanilinopyrimidine derivatives for use as antiviral agents